AMP-activated protein kinase: a key stress signaling pathway in the heart.

[1]  M. Prentki,et al.  Adenosine 5'-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes. , 2005, Endocrinology.

[2]  L. Witters,et al.  Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart , 2005, Circulation research.

[3]  G. Lopaschuk,et al.  Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5′-AMP-activated Protein Kinase Kinase* , 2005, Journal of Biological Chemistry.

[4]  G. Taffet,et al.  Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.

[5]  B. Viollet,et al.  The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. , 2004, Diabetes.

[6]  R. Russell,et al.  Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[7]  D. Hardie,et al.  AMP-activated protein kinase: the guardian of cardiac energy status. , 2004, The Journal of clinical investigation.

[8]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[9]  D. Hardie,et al.  Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. , 2004, American journal of physiology. Endocrinology and metabolism.

[10]  Anita Y. M. Chan,et al.  Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.

[11]  R. Takeda,et al.  AMP-Activated Protein Kinase Inhibits Angiotensin II– Stimulated Vascular Smooth Muscle Cell Proliferation , 2004, Circulation.

[12]  A. Ashworth,et al.  LKB1 Kinase: Master and Commander of Metabolism and Polarity , 2004, Current Biology.

[13]  E. Ojuka.  Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle , 2004, The Proceedings of the Nutrition Society.

[14]  H. Ronne,et al.  Snf1‐related protein kinase 1 is needed for growth in a normal day–night light cycle , 2004, The EMBO journal.

[15]  David Carling,et al.  Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status* , 2004, Journal of Biological Chemistry.

[16]  C. Proud,et al.  Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398* , 2004, Journal of Biological Chemistry.

[17]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[18]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[20]  J. Holloszy,et al.  Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. , 2004, Diabetes.

[21]  D. Hardie,et al.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. , 2004, The Journal of clinical investigation.

[22]  B. Kemp.  Bateman domains and adenosine derivatives form a binding contract. , 2004, The Journal of clinical investigation.

[23]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[24]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[25]  David Carling,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[26]  M. Birnbaum,et al.  Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes* , 2003, Journal of Biological Chemistry.

[27]  D. Vertommen,et al.  Myocardial Ischemia and Increased Heart Work Modulate the Phosphorylation State of Eukaryotic Elongation Factor-2* , 2003, Journal of Biological Chemistry.

[28]  I. Shiojima,et al.  Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.

[29]  Minyoung Lee,et al.  AMP-activated Protein Kinase Activity Is Critical for Hypoxia-inducible Factor-1 Transcriptional Activity and Its Target Gene Expression under Hypoxic Conditions in DU145 Cells* , 2003, Journal of Biological Chemistry.

[30]  Jérôme Boudeau,et al.  Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.

[31]  N. Fujii,et al.  Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.

[32]  Yu Hong,et al.  AMP-activated Protein Kinase Regulates HNF4α Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability* , 2003, Journal of Biological Chemistry.

[33]  Ferhaan Ahmad,et al.  Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.

[34]  G. Shulman,et al.  Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. , 2003, American journal of physiology. Endocrinology and metabolism.

[35]  B. Kemp,et al.  AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen , 2003, Current Biology.

[36]  P. Light,et al.  Constitutively Active Adenosine Monophosphate–Activated Protein Kinase Regulates Voltage-Gated Sodium Channels in Ventricular Myocytes , 2003, Circulation.

[37]  N. Kimura,et al.  A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[38]  D. Carling,et al.  Functional Analysis of Mutations in the γ2 Subunit of AMP-activated Protein Kinase Associated with Cardiac Hypertrophy and Wolff-Parkinson-White Syndrome* , 2002, The Journal of Biological Chemistry.

[39]  G. Shulman,et al.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[41]  David Carling,et al.  The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[42]  D. Hardie,et al.  Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. , 2002, American journal of physiology. Endocrinology and metabolism.

[43]  A. Means,et al.  AMP-activated protein kinase kinase: detection with recombinant AMPK α1 subunit , 2002 .

[44]  M. Gorospe,et al.  AMP-Activated Kinase Regulates Cytoplasmic HuR , 2002, Molecular and Cellular Biology.

[45]  Y. Hellsten,et al.  Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. , 2002, Diabetes.

[46]  J. Seidman,et al.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[47]  J. Balschi,et al.  The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart* , 2002, The Journal of Biological Chemistry.

[48]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[49]  J. Seger,et al.  Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy , 2001, Circulation.

[50]  R. Bartrons,et al.  Adenosine monophosphate–activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia‐reperfusion injury in the rat , 2001, Hepatology.

[51]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[52]  L. Goodyear,et al.  Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy , 2001, Circulation.

[53]  S. J. Kim,et al.  The regulation of AMP-activated protein kinase by H(2)O(2). , 2001, Biochemical and biophysical research communications.

[54]  N. Ruderman,et al.  Acute Regulation of Fatty Acid Oxidation and AMP-Activated Protein Kinase in Human Umbilical Vein Endothelial Cells , 2001, Circulation research.

[55]  L. Fananapazir,et al.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. , 2001, The New England journal of medicine.

[56]  M. Bucan,et al.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.

[57]  H. Watkins,et al.  Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.

[58]  D. Severson,et al.  Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter. , 2001, American journal of physiology. Endocrinology and metabolism.

[59]  B. Kemp,et al.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. , 2001, The Biochemical journal.

[60]  E. Kraegen,et al.  Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. , 2001, Biochemical Society transactions.

[61]  G. Lopaschuk,et al.  AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart. , 2001, Biochemical Society transactions.

[62]  D J Campbell,et al.  AMP-activated protein kinase, super metabolic regulator. , 2001, Biochemical Society transactions.

[63]  L. Andersson.  Identification and characterization of AMPK γ3 mutations in the pig , 2001 .

[64]  D. Carling,et al.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.

[65]  G. Vallega,et al.  UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. , 2000, American journal of physiology. Endocrinology and metabolism.

[66]  M. Prentki,et al.  Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside* , 2000, The Journal of Biological Chemistry.

[67]  B. Kemp,et al.  Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. , 2000, The Journal of clinical investigation.

[68]  D. Carling,et al.  The regulation of AMP-activated protein kinase by phosphorylation. , 2000, The Biochemical journal.

[69]  B. Lowell,et al.  Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. , 2000, Diabetes.

[70]  N. Ruderman,et al.  The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. , 1999, Biochemical and biophysical research communications.

[71]  G. Shulman,et al.  Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. , 1999, The American journal of physiology.

[72]  G. Shulman,et al.  Regulation of myocardial glucose uptake and transport during ischemia and energetic stress. , 1999, The American journal of cardiology.

[73]  D. Hardie,et al.  Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. , 1999, European journal of biochemistry.

[74]  G. Shulman,et al.  Effect of AMPK activation on muscle glucose metabolism in conscious rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[75]  R. Coleman,et al.  AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. , 1999, The Biochemical journal.

[76]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[77]  A. Prescott,et al.  AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. , 1998, The Biochemical journal.

[78]  Tatsuya Hayashi,et al.  Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport , 1998, Diabetes.

[79]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.

[80]  Mangano Dt.  Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. , 1997, JAMA.

[81]  D. Mangano.  Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. , 1997, JAMA.

[82]  G. Shulman,et al.  Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. , 1997, Circulation.

[83]  L. Witters,et al.  Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.

[84]  D. Hardie,et al.  Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. , 1996, The American journal of physiology.

[85]  A. Edelman,et al.  5′-AMP Activates the AMP-activated Protein Kinase Cascade, and Ca2+/Calmodulin Activates the Calmodulin-dependent Protein Kinase I Cascade, via Three Independent Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[86]  G. Lopaschuk,et al.  High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*) , 1995, The Journal of Biological Chemistry.

[87]  D. Hardie,et al.  Roles of the Snf1/Rkin1/AMP-activated protein kinase family in the response to environmental and nutritional stress. , 1994, Seminars in cell biology.

[88]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.

[89]  D. Hardie.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status , 2022 .